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Abstract
Docosahexaenoic acid (DHA) is a ω-3 fatty acid typically obtained from the diet or 
endogenously synthesized through the action of elongases (ELOVLs) and desaturases. 
DHA is a key central nervous system constituent and the precursor of several mol-
ecules that regulate the resolution of inflammation. In the present study, we questioned 
whether the impaired synthesis of DHA affected neural plasticity and inflammatory 
status in the adult brain. To address this question, we investigated neural and inflam-
matory markers from mice deficient for ELOVL2 (Elovl2−/−), the key enzyme in DHA 
synthesis. From our findings, Elovl2−/− mice showed an altered expression of markers 
involved in synaptic plasticity, learning, and memory formation such as Egr-1, Arc1, 
and BDNF specifically in the cerebral cortex, impacting behavioral functions only 
marginally. In parallel, we also found that DHA-deficient mice were characterized by 
an increased expression of pro-inflammatory molecules, namely TNF, IL-1β, iNOS, 
caspase-1 as well as the activation and morphologic changes of microglia in the ab-
sence of any brain injury or disease. Reintroducing DHA in the diet of Elovl2−/− mice 
reversed such alterations in brain plasticity and inflammation. Hence, impairment of 
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original 
work is properly cited.
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systemic DHA synthesis can modify the brain inflammatory and neural plasticity sta-
tus, supporting the view that DHA is an essential fatty acid with an important role in 
keeping inflammation within its physiologic boundary and in shaping neuronal func-
tions in the central nervous system.
K E Y W O R D S
anti-inflammatory molecules, brain plasticity, microglia, omega-3, PUFA
1 |  INTRODUCTION
The main ω-3 polyunsaturated fatty acid (PUFA) of the brain 
is docosahexaenoic acid (DHA), which is a key structural com-
ponent of neuronal membrane phospholipids and plays an es-
sential role in brain development and function.1,2 DHA cannot 
be synthesized de novo in mammals and need to be synthesized 
from the essential dietary fatty acid α-linolenic acid (ALA) 
through a series of elongation and desaturation reactions per-
formed by distinct enzymes residing in the endoplasmic retic-
ulum.3 Indeed, DHA biosynthesis requires three elongation 
steps, the last two of which are catalyzed by elongation of long-
chain fatty acids 2 (ELOVL2), an enzyme that is significantly 
expressed in liver, testis, retina and central nervous system 
(CNS), tissues that are particularly rich in DHA.4-6
DHA is essential for CNS functions, including neurite out-
growth and synaptogenesis,7 brain-derived neurotrophic factor 
(BDNF)-induced neuronal survival,8 synaptic integrity and neu-
rotransmission9 as well as protection from neuroinflammatory 
processes, and cognitive decline.10 Indeed, a DHA deficient 
diet is involved in the pathophysiology of memory impairment 
and several mood disorders such as anxiety and depressive-like 
behaviors.11-15 DHA deficiency in the CNS is also paralleled 
by an increased expression of pro-inflammatory cytokines and 
a modification of neuronal plasticity-related gene expression, 
including the early growth response protein 1 (Egr-1) and the 
activity-regulated cytoskeleton-associated protein (Arc-1),16 ul-
timately associated with learning and memory formation.17,18 
Such evidence prompted the investigation of several clinical tri-
als with DHA on neurodevelopmental disorders, including au-
tism and attention-deficit/hyperactivity disorder.19 Despite the 
fact that there is a growing number of trials testing the efficacy 
of n-3 PUFAs in the treatment of different psychiatric disorders, 
only a few studies investigated the efficacy of DHA alone on 
cognitive functions. Moreover, the small number of trials on 
cognitive impairment in psychiatric disorders shows doubtful 
and/or contrasting results that need further investigations.20,21
Moreover, the role of DHA in inflammation is already 
consolidated and is receiving greater attention mainly due 
to the discovery that it serves as a metabolic precursor for a 
new genus of anti-inflammatory molecules, that is, resolvins, 
neuroprotectins, and maresins, that are involved in the spon-
taneous but active process of resolution of inflammation,21,22 
which mainly involves myeloid cells such as macrophages and 
glial cells.23,24 Indeed, we have recently shown that the impair-
ment of systemic DHA synthesis in Elovl2−/− mice, delineates 
an immunophenotypical alteration of M1/M2 macrophages, 
with M1 being more pro-inflammatory and M2 less protec-
tive, supporting the view that DHA has a relevant role in con-
trolling inflammatory responses.25 Given that DHA plays a 
key role in CNS function and plasticity and is a potent anti-in-
flammatory mediator, we sought to systematically investigate 
whether Elovl2−/− mice, characterized by a systemic impair-
ment of endogenous DHA synthesis, displayed neuronal plas-
ticity dysfunctions and brain inflammation and whether such 
alterations could be restored upon DHA supplementation.
2 |  MATERIAL AND METHODS
2.1 | Ethics statement for experimental 
animals
This study was approved by the Institutional Review Board on 
Animal Studies of Stockholm University and by the Animal 
Ethics Board of the North Stockholm region, and performed in 
accordance with national guidelines and regulations for the care 
and use of laboratory animals in agreement with the guidelines 
of the European Communities Council Directive 2010/63/EU 
for the care and use of laboratory animals. All efforts were made 
to minimize the number of animals used and their suffering.
2.2 | Animals and tissue processing
Elovl2−/− mice were generated as described previously26 and 
backcrossed into the 129S2/Sv strain for five generations. All 
animals were housed at room temperature and maintained on 
a 12 hours light/dark cycle. About 20-25 weeks old male or 
female mice were fed standard chow DHA-free diet (10% kcal 
fat, D12450H, Research Diets, New Brunswick, NJ, USA) or 
DHA-enriched (10% kcal fat, 1% DHA, D13021002, Research 
Diets, New Brunswick, NJ, USA) for 3 months, according to 
the experimental groups. Dietary fatty acid composition and 
other nutrients are shown in Tables 1 and 2. All animals were 
fed ad libitum and had free access to water. At the end of the 
E/C/000I0420; Svenska Forskningsrådet 
Formas (Swedish Research Council 
Formas), Grant/Award Number: IB13-0026
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study, animals were euthanized with CO2 and killed by cervi-
cal dislocation. Brains were removed immediately, dissected, 
and stored in liquid nitrogen or in 4% paraformaldehyde.
2.3 | HPLC analysis of acyl-CoA fatty acids
Brain tissues were ground to a powder and 6 mg extracted27 
for reverse-phase LC (Agilent 1200 LC system; Gemini C18 
column, 2 mm inner diameter, 150 mm with 5 mm particles) 
with electrospray ionisation tandem mass spectrometry (multi 
reaction monitoring, MRM) on a QTRAP 4000 (SCIEX) in-
strument in positive ion mode. LC-MS/MS MRM analysis 
followed the methods previously described.28 A total of 68 
acyl-CoA fatty acids (14:0 to 34:6) were tracked using indi-
vidual MRM mass pairs. For identification and calibration, 
standard acyl-CoA esters with acyl chain lengths from C14 to 
C20 were purchased from Sigma as free acids or lithium salts.
2.4 | Western blotting
Whole brains and the cerebral cortex were collected, ho-
mogenized, and proteins were extracted in Ripa buffer 
(Milli-Q Water, Tris hydrochloride 0.05 M pH 7.4, 0.001 M 
potassium chloride, 0.0015  M magnesium chloride, 
0.001  M EDTA, 0.001  M dithiothreitol, 0.005  M sodium 
fluoride, 0.001  M sodium metavanadate, 0.1% SDS, 10% 
Na-DOC,1% Triton X-100, 1X protease inhibitor cocktail 
(Sigma, P8340), for 20 minutes on ice, and then were cen-
trifuged for 15 minutes at 4°C (14 000 rpm). Supernatants 
were collected and transferred in a 1.5 mL vial. The total 
protein content of the resulting supernatant was quantified 
by the Bradford's colorimetric assay (Bio-Rad, Milan, Italy). 
Each protein sample was separated by SDS-polyacrylamide 
gel electrophoresis and transferred to a nitrocellulose mem-
brane. Membranes were saturated with 5% dried nonfat 
milk and incubated overnight at 4 degrees C with specific 
Fatty acids
not DHA-enriched diet (10% kcal 
fat) D12450H
DHA-enriched diet (10% 
kcal, 1% DHA) D13021002
C12:0 0.09 0.05
C14:0 0.80 0.48
C15:0 0.05 0.05
C16:0 16.83 12.48
C16:1n-9 0.17 0.09
C16:1n-7 0.86 0.51
C18:0 8.43 5.35
C18:1n-9 27.87 21.35
C18:1n-7 1.66 1.29
C18:2n-6a 37.43 35.64
C18:3n-6 0.16 0.19
C18:3n-3b 4.24 4.46
C20:0 0.30 0.23
C18:4n-3 0.05 0
C20:1n-9 0.37 0.25
C20:2n-6 0.31 0.19
C20:4n-6 0.11 0.24
C22:0 0.24 0.20
C20:4n-3 0 0.03
C20:5n-3 0 0.71
C22:3n-3 0 0.08
C22:4n-6 0 1.04
C22:5n-3 0 0.57
C22:6n-3c 0 14.53
Note: Fatty acids expressed as % of total fatty acids of control diet (10% kcal fat, D12450H, Research Diets, 
New Brunswick, NJ, USA) and DHA-enriched diet (10% kcal fat, 1% DHA, D13023002, Research Diets, New 
Brunswick, NJ, USA).
aLA (linoleic acid). 
bALA (α-linolenic acid). 
cDHA (docosahexaenoic acid). 
T A B L E  1  Diet fatty acid composition
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primary antibodies. Membranes were then incubated with 
the appropriate horseradish peroxidase-conjugated second-
ary antibodies. Immunoreactive bands were detected using 
an enhanced chemiluminescence kit (ECL; Amersham 
Biosciences). The relative levels of immunoreactivity were 
determined by densitometry using the software ImageQuant 
5.0. Samples were incubated with the following primary 
antibodies: rabbit anti-Caspase 1 (1:1000, Cell Signaling, 
Danvers, MA, USA); monoclonal mouse anti-Arc (1:200, 
Santa Cruz Biotechnology, Dallas, TX, USA), rabbit anti-
Iba1 (1:500, Wako, Japan), rabbit anti-GFAP (1:1000, 
#AB5804 Merck Millipore, Burlington, MA, USA), mouse 
anti-actin (1:1000, Cell Signaling), mouse anti-Egr-1 (1:500, 
Santa Cruz Biotechnology), and mouse anti-BDNF (1:500, 
Immunological Science, Rome, Italy). Densities of protein 
bands in the Western blots were measured with ImageJ and 
mean ratios between proteins and actin were reported as a 
percentage of control values.
2.5 | qRT-PCR
Total RNA was isolated with TRI Reagent (Sigma-Aldrich) 
and total RNA was isolated following the manufacturer's pro-
cedure. For real-time PCR, 500  ng total RNA was reverse 
transcribed using random hexamer primers, deoxynucleoside 
triphosphates, MultiScribe reverse transcriptase, and RNase 
inhibitor (Applied Biosystems, Foster City, CA). cDNA sam-
ples were diluted 1:10 and aliquots of 2 μl per reaction were 
run in duplicate. Thermal cycling conditions were 2 minutes 
at 50°C, 10 minutes at 95°C, and 40 cycles of 15 s at 95°C 
and 1 minutes at 60°C, followed by the melting curve analy-
sis on a Bio-Rad CFX Connect Real-Time system. Primers 
used for qRT-PCR were caspase-1, inducible nitric oxide 
synthase (iNOS), interleukin 1β (IL-1β), tumor necrosis fac-
tor (TNF), activity-regulated cytoskeleton-associated protein 
1 (Arc-1), early growth response protein 1 (Egr-1), brain-de-
rived neurotrophic factor (BDNF), and glial fibrillary acidic 
protein (GFAP). Actin and transcription factor IIB (TFIIB) 
were used as housekeeping genes for quantity normalization. 
For primers’ sequences see Table 3.
2.6 | Behavioral testing
Behavioral testing took place during a fixed time window 
from 1 PM to 5 PM, depending on a number of tests. This 
is toward the end of the light cycle (6 AM to 6 PM). About 
28 mice at 6-10 months of age were used for behavioral test-
ing. Males and females were always tested separately and all 
Ingredient
Control Diet (10% kcal 
fat) D12450H
DHA-Enriched Diet (10% kcal 
fat, 1% DHA) D13021002
Casein 200 200
L-cystine 3 3
Cornstarch 452.2 452.2
Maltodextrin 10 75 75
Sucrose 172.8 172.8
Cellulose, BW200 50 50
Soybean oil 25 25
DHA 0 10
Lard 20 10
Mineral mix S10026 10 10
Dicalcium phosphate 13 13
Calcium carbonate 5.5 5.5
Potassium citrate, 1H20 16.5 16.5
Vitamin mix V10001 10 10
Choline bitartrate 2 2
FD&C yellow dye #5 0.04 0
FD&C red dye #40 0.01 0.025
FD&C blue dye #1 0 0.025
Total (g) 1055.5 1055.05
Note: Diet composition expressed in gram of mass for each ingredient, of control diet (10% kcal fat, D12450H, 
Research Diets, New Brunswick, NJ, USA) and DHA-enriched diet (10% kcal fat, 1% DHA, D13023002, 
Research Diets, New Brunswick, NJ, USA) formulated by Research Diets, New Brunswick, NJ, USA.
T A B L E  2  Diet composition
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maintained on a standard diet. In all nonautomated test re-
cordings, two observers were present. Observers were placed 
in a fixed position in each test, for example, on opposing 
sides of a mesh grid. Prior to testing, all animals had at least 
one week of acclimatization following rehousing or arrival 
to the animal house. For the open field activity, ambulation 
levels as well as anxiety were examined with the open field 
test described in,29 using a square area with light grey floor 
and clear Plexiglass walls (50 × 50 × 38 cm surrounded by to 
frames of light beams; at 3 cm above the arena floor to detect 
movements and at 6 cm above the arena floor to detect rear-
ing events (ActiMot system, TSE systems, Germany). The 
light level in the center of the arena floor was adjusted to 150-
200 lux. Explorative behavior was recorded for 90 minutes. 
During this period the following behavioral characteristics 
were evaluated: a) ambulation; b) rearing; c) immobility. For 
the novel object recognition (NOR) experiments, mice (n = 7 
per experimental group) were acclimatized in a 29 × 29 cm 
square cage (arena) made of yellow “plastic” with 35 cm high 
walls for 5 minutes just prior the training. During the training 
trial, two identical plastic objects with particular shapes and 
colors were presented. The mouse was allowed to explore 
both objects for a cumulative time of 10 seconds (cut-off time 
15 min). After a 24 hours inter-trial interval (ITI), one of the 
familiar objects was replaced by a novel object, with a differ-
ent shape and color, to test for memory retention. The mouse 
was again allowed to explore both objects for a cumulative 
time of 10  seconds (cut-off time 15  min) and exploration 
of an object was defined as pointing the nose to the object 
(within 1 cm distance from the object) and/or touching the 
object with the nose. Analysis was based on the time spent 
exploring the novel and the familiar objects.29 For the Barnes 
maze test, we tested only female animals. This test occurs 
on a circular platform (Ø125 cm, elevated 70 cm above the 
floor) with 36 escape holes ringed around the center of the 
platform. Bright overhead lighting creates an aversive stimu-
lus, encouraging the animal to escape the light through the 
Target Escape Hole, which is attached to an escape box. 
Visual cues placed around the maze act as spatial cues. In this 
test, we used a shortened protocol developed by Attar et al,30 
with five training trials over 2 days followed by the probe 
trial on the third day. This protocol emphasizes the early 
learning phase and is more sensitive with respect to discrete 
spatial learning difficulties/memory consolidation than the 
standard protocol with 15 training trials. The only aversive 
stimulus used was light (approx. 400-500 lux in the center 
of the arena). All tests were recorded with a high-resolution 
video camera at 15 frames per second and analyzed with the 
Ethovision XT 11 software (Noldus IT, The Netherlands).
2.7 | Histology and immunohistochemistry
Mice were perfused transcardially with 20 mL of saline fol-
lowed by 20 mL of 4% paraformaldehyde in phosphate buffer 
(PB; 0.1 M; pH 7.4) under anesthesia induced by  i.p.  injec-
tion of sodium pentobarbital (60 mg/kg). Each brain was re-
moved immediately, postfixed in the same fixative for 2 hours 
and, after three washes in PB, transferred to 30% sucrose in 
PB solution at 4°C until they sank. Brains were cut into four 
series of 30 μm-thick transverse sections by means of a freez-
ing microtome and were collected in PB. The sections were 
incubated overnight with a cocktail of primary antibodies, one 
of this including rabbit anti-GFAP (1:1000; #Z0334, Dako 
Agilent, Santa Clara, CA, USA), rabbit anti-Iba1 (1:700; 
Wako, Japan), goat anti-Iba1 (1:400; Abcam, Cambridge, 
MA, USA), rabbit anti-TMEM-119 (1:400; Abcam), goat 
anti-IL-1β (1:200; R&D Systems, Minneapolis, MN, USA), 
and goat anti-TNF (1:200; R&D Systems, Minneapolis, 
MN, USA). All primary antibody solutions were prepared 
in PB and 0.3% Triton X-100 and were incubated overnight. 
Afterward, sections were incubated for 2 hours at RT with 
a cocktail of secondary antibodies, including Alexa Fluor 
488 conjugated donkey anti-mouse (1:200; Thermo Fisher 
Scientific, Waltham, MA USA), Alexa Fluor 555 conjugated 
donkey anti-rabbit (1:200), Alexa Fluor 488 conjugated 
T A B L E  3  Murine primers used for the quantitative RT-PCR
Primers Forward Reverse
Casp1 GGACATCCTTCATCCTCAGAAACA TTTCTTTCCATAACTTCTGGGCTTT
iNOS TCTCCCTTTCCTCCCTTCTT CTTCAGTCAGGAGGTTGAGTTT
IL-1β TGCCACCTTTTGACAGTGATG AAGGTCCACGGGAAAGACAC
TNF CCACATCTCCCTCCAGAAA CTTCTGCCAGTTCCACGTC
Egr-1 AGCGAACAACCCTATGAGCA ATAACTCGTCTCCACCATCCGC
BDNF TGGCATCTACCCACACACTTT TCAGTTTGTTCGGCTCCACT
GFAP GGCCCTGAGAGAGATTCGC ACCGATACCACTCCTCTGTGCT
Arc-1 ACGATCTGGCTTGGTCATTCTGG AGGTTCCCTGAGCATGTCTGCTT
TFIIB TGGAGATTTGTCCACCATGA GAATTGCCAAACTCATCAAAACT
B-actin AGTCCCTGCCCTTTGTACACA CGATCCGAGGGCCTCACTA
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donkey anti-rabbit (1:200), and Alexa Fluor 555 conjugated 
donkey anti-goat (1:200). Sections were also counterstained 
with Neuro-Trace 640⁄660 deep-red Fluorescent Nissl Stain 
(1:200; Thermo Fisher Scientific). After further washes in 
PBS, the sections were mounted using an anti-fade medium 
(Fluoromount; Sigma, Milan, Italy) and examined under 
a confocal laser-scanning microscope (Zeiss CLSM700, 
Oberkochen Germany). The specificity of immunohisto-
chemical labeling was confirmed by the omission of primary 
antibodies and the use of normal serum instead (negative 
controls). Confocal acquisition of the brain area of interest 
(motor cortex and somatosensory cortex) was identified by a 
10 × objective (Plan-Apochromat, Zeiss; NA = 0.30; zoom 
factor 0.5) and captured through a confocal laser-scanning 
microscope (CLSM700; Zeiss, Oberkochen, Germany). 
The following acquisition settings were used: image format 
1024 × 1024; image size 1279.1 × 1279.1 μm; Airy Units 
1.0 producing an optical section thickness of 5.2 μm; pixel 
dwell time 12.61 μs. The confocal image acquisitions were 
performed so that all samples were captured using consist-
ent settings for laser power and detector gain. Images were 
exported in the TIFF format, contrast and brightness were 
adjusted only during image processing for counting to ensure 
that fluorescence intensity of Iba1 staining falls within the 
linear range for each sample to provide uniform visualization 
of cells. Final plates were composed with Adobe Illustrator 
CS3.
2.8 | Quantitative analysis of microglia
To assess microglia and astrocytes proliferation in the 
cerebral cortex (motor cortex and sensorimotor cortex), 
quantitative analyses were performed off-line on confo-
cal images acquired through the 10x objective at the 0.7 
zoom factor. Specifically, all labeled cells in two rectangu-
lar boxes (100 µm width × 200 µm length) randomly posi-
tioned in five regularly spaced sections were counted. Iba1 
or GFAP-immunolabeled cells were digitally marked and 
recorded, and data were stored in an archive as previously 
described.31
To assess microglial morphological features, quantitative 
analyses were performed on-line on sections stained with 
Iba1 and counterstained with Neuro-Trace to identify the 
areas of interest. Sections were visualized using an optical 
microscope (DMLB, Leica, Wetzlar, Germany) equipped 
with a motorized stage and a camera connected to soft-
ware (Neurolucida 7.5, MicroBrightField). Iba1 positive 
cells were reconstructed under a Zeiss Axio Plan objective 
(NEOFLUAR × 100 objective with a numerical aperture of 
1.3 under oil immersion). The only microglia that displayed 
intact processes unobscured by background labeling or other 
cells were included in reconstructions. Microglia were traced 
throughout the entire thickness of the section (30 μm) to ac-
quire morphometric analysis of the cell body (cross-sectional 
area and perimeter) and the processes ramification (number 
of branch nodes and intersections) (Table 4). To account for 
changes in the cell's complexity in relation to distance from 
the cell soma, Sholl analysis was performed for each cell. 
Concentric circles (radii) were spaced 10  μm apart, origi-
nating from the soma. The number of branch points (nodes), 
processes that intersected the radii, was measured as a func-
tion of the distance from the cell soma for each radius.24,32 
Data were collected and stored for statistical analysis. Fifteen 
cells per animal were randomly selected for a total of 90 cells 
per group (N = 6 mice/group) and included for analysis. All 
quantitative analyses were conducted blind to the animal's ex-
perimental group assignment.
2.9 | ELISA assay
The cytokine content was determined by standard two-site 
sandwich ELISAs, using the available commercial kits for 
IL-1β (detection limit 2 pg/mL) (eBioscience, ready-set-go), 
according to manufacturer's instructions.
2.10 | Statistical analysis
Data were expressed as mean ± SEM and were analyzed by 
means of Prism 4 software (GraphPad Software, San Diego, 
CA). Differences between two or multiple groups were ana-
lyzed by means of the Student's t test or one-way ANOVA 
followed by Bonferroni post hoc test or Tukey's test. A P 
value <.05 was considered significant. Since there were no 
gender-related differences, data from male and female mice 
were pooled together. For each experiment, except for behav-
ioral studies, 40% males and 60% females were randomized 
between the groups.
T A B L E  4  Summary of microglia morphology measures
 
Unit of 
measure Sampling Interpretation
Perimeter of the cell 
body
µm 15 cells per 
animal
Cell body size
Cross-sectional area 
of the cell body
µm2 15 cells per 
animal
Cell body size
Processes  
intersection (with 
each radius)
Number (per 
radius)
15 cells per 
animal
Cell ramification
Branch points 
(nodes) for each 
radius
Number (per 
radius)
15 cells per 
animal
Cell ramification
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3 |  RESULTS
3.1 | DHA deficiency affects fatty acid 
composition in adult brains
To directly link PUFA synthesis in the brain with alterations 
in brain plasticity and inflammation, we profiled for the first 
time the acyl-CoA composition of various fatty acids in the 
brain tissues of Elovl2−/− (KO) and wild-type (WT) mice 
using targeted metabolite monitoring via liquid chromatog-
raphy in combination with mass spectrometry (LC-MS/MS) 
(Figure 1A). Such lipidomic analysis allowed us to detect 
several fatty acids derived both from alpha-linolenic acid 
(n-3) and linoleic acid (n-6), namely the metabolic pool in 
which the Elovl enzymes work. In particular, although most 
fatty acids were detectable in both WT and KO mice (Figure 
1A,B), we observed a significant accumulation of alpha- 
linolenic acid-derived eicosapentaenoic acid (EPA) (20:5n-3) 
and docosapentaenoic acid (DPA) (22:5n-3) coupled with, 
as expected, markedly reduced the levels of DHA (22:6n-
3) in the brain of KO mice (Figure 1C). Interestingly, since 
Elovl2 is also involved in the elongation of linoleic acid-de-
rived n-6 fatty acids, KO mice displayed a general, yet not 
significant, accumulation of linoleic acid itself (18:2n-6) 
and dihomo-γ-linoleic acid (20:3n-6), and a significant ac-
cumulation of docosatetraenoic acid (20:5n-6) (Figure 1C). 
Furthermore, when looking at other n-3 and n-6 fatty acids, 
such as 20:3n-3, 20:4n-3 or 22:4n-6, we did not observe 
any significant change between WT and KO brain tissues 
(Table 5). Similarly, also several saturated fatty acids, such as 
arachidic acid (20:0), behenic acid (22:0), and lignoceric acid 
(24:0), were unchanged between WT and KO brains, with 
the exception of stearic acid (18:30) that was significantly 
reduced in KO brains (Table 5).
3.2 | DHA deficiency affects synaptic 
plasticity genes
Next, we questioned whether several markers of brain plastic-
ity were affected following impaired DHA synthesis. To do so, 
we analyzed the expression of several well-known plasticity 
F I G U R E  1  Biosynthesis of fatty acids in wild-type (WT) and Elovl2−/− (KO) mice brains. A-B, Representative spectra of WT and KO 
mice fed standard chow diet (no DHA) and determined by extraction, derivatization, and LC-MS/MS analysis of acyl-etheno-CoAs fatty acids. C, 
Composition of key n-6 and n-3 fatty acids in the brain of WT and KO. Results shown are means ± SEM from seven animals per group. *P < .05, 
**P < .01, and ***P < .001
T A B L E  5  Composition of other n-6, n-3, and saturated fatty 
acids in the brain of WT and KO
Acyl-CoA fatty 
acid WT (μmol/mg) KO (μmol/mg)
C12:0 15.98 ± 0.89 14.21 ± 0.59
C14:0 5.73 ± 0.55 6.06 ± 0.68
C15:0 1.01 ± 0.17 1.13 ± 0.22
C16:0 9.55 ± 1.65 11.07 ± 1.23
C16:1n-9 3.74 ± 0.80 3.86 ± 0.75
C16:1n-7 0.66 ± 0.04 0.85 ± 0.08
C18:0 4.45 ± 0.98 4.72 ± 0.95
Note: Results shown are means ± SEM from seven animals per group.
*P < .05. 
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factors that are rapidly and selectively regulated in specific 
brain regions associated with learning and memory, including 
Arc-1, Egr-1, and BDNF.33,34 Considering that the expression 
of these factors has previously been shown to be regulated by 
ω-3 polyunsaturated fatty35,36 we measured the gene expres-
sion of Arc-1, Egr-1, and BDNF in the total brain and cerebral 
cortex. Interestingly, the expression of these neuroplasticity 
immediate early genes did not show any significant variation 
in the total brains of KO mice compared to WT (Figure 2). 
However, when analyzing them in the cerebral cortex, we ob-
served that the mRNA expression of Egr1 and its direct target 
Arc1, as well as of BDNF was significantly down-regulated 
in KO mice compared to WT (Figure 2). When trying to cor-
roborate such findings in the cortex by analyzing their protein 
levels, we observed that only Arc-1 was significantly reduced 
in KO mice compared to WT, whereas no significant change 
was observed for BDNF and Egr-1 (Figure 2).
3.3 | DHA deficiency induces 
neuroinflammation but has a small impact on 
behavioral functions
As already shown by our previous studies where impairment 
of systemic DHA synthesis affects specific immune cells, 
such as T-helper cells and macrophages37,38 and given the 
important role of DHA in inflammatory responses, we next 
examined whether the deficient synthesis of this essential 
fatty acid can modulate the brain inflammatory status. For 
this purpose, we examined the expression of several markers 
F I G U R E  2  Synaptic plasticity markers expression is impaired in the cerebral cortex of KO mice. mRNA expression of Egr-1, Arc-1, and 
BDNF in the total brain and their mRNA and protein in the cortex of WT and KO mice by RT-PCR and western blotting. Data are shown as 
mean ± SEM of seven animals per group (WT and KO), each in duplicate. *P < .05 and ***P < .001 vs WT by unpaired Student's t test
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of brain inflammation in total brain and cerebral cortex of KO 
and WT mice, among which the major pro-inflammatory cy-
tokines in the brain (TNF and IL-1β), inducible nitric oxide 
synthase (iNOS), and caspase-1 (Casp1), all of which play a 
key role in the onset and progression of neuroinflammatory 
diseases.39 In particular, the total brains of KO mice showed a 
significant increase in iNOS gene expression but no variation 
in TNF, IL-1β, and Casp1 (Figure 3A,B) compared to WT 
mice. However, Casp1 protein expression was significantly 
higher in KO mice compared to WT (Figure 3B). Conversely, 
when investigating the expression of these pro-inflammatory 
markers in the cerebral cortex, we observed that mRNAs of 
both cytokines, as well as iNOS and Casp1, were significantly 
up-regulated in KO mice. Since Casp1 is usually in its physi-
ologically inactive zymogen form and requires cleaving into 
its p20 subunit to display its pro-inflammatory activity,40 we 
also analyzed the protein expression of its biologically active 
fragment p20 in WT and KO mice and we found that KO mice 
showed a significant increase in p20-casp1 expression com-
pared to WT mice (Figure 3A,B), thus confirming a higher 
inflammatory status in mice deficient for DHA synthesis.
Since the presence in the brain of inflammatory markers 
like cytokines and iNOS is linked to glial cells’ activation, we 
next investigated the effect of endogenous DHA deficiency 
on astrocytes and microglia functional state and their mor-
phology in the cerebral cortex. Although quantitative anal-
ysis of cortical GFAP protein level and GFAP positive and 
reactive astrocytes did not show any significant differences 
between KO and WT mice (Figure 4D-F), we observed a sig-
nificant increase of Iba1 protein level and in the number of 
Iba1 + cells in the cerebral cortex of KO mice compared to 
WT (Figure 4A-C), suggesting that DHA-deficient mice dis-
played not only an increased number of microglia, but these 
cells displayed a different morphological state. Interestingly, 
when closely observing the morphology of Iba1 + microglia, 
we noticed that the microglia of KO mice showed different 
morphological features. Thus, we performed Sholl analysis 
and found that the cerebral cortex of KO mice microglia 
displayed a higher degree of complexity and ramification 
compared to those of WT, presenting a larger cell body (in-
crease perimeter and cross-sectional area) (Figure 4A, inset) 
as well as an increased number of intersections and nodes 
F I G U R E  3  Inflammatory markers expression is impaired in the cerebral cortex of KO mice. A-B, mRNA expression of TNF, IL-1β, iNOS, 
and Casp1 as well as protein expression of Casp1(p20) in total brain and cortex of WT and KO mice by qRT-PCR and western blotting. Data are 
shown as mean ± SEM of seven (qRT-PCR) or four (western blotting) animals per group (WT and KO), each in duplicate. *P < .05 vs WT by 
unpaired Student's t test
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F I G U R E  4  DHA deficiency alters microglia response without affecting astrogliosis. A, Immunofluorescence staining of microglia (Iba1) in 
the cerebral cortex of WT and KO mice. Double-labeled and merged confocal images of Iba1 (red) plus NeuroTrace Nissl staining (green) (scale 
bars = 100 μm). Insets: Single-labeled images of Iba1 staining (scale bars = 10 μm). B, Western blotting and its densitometry of Iba1. Immunoblot 
images are cropped from different parts of the same gel. C, Histogram of the number of Iba1 positive cells in the cerebral cortex of WT and KO 
mice. D, Immunofluorescence staining of astrocytes (GFAP) in the cerebral cortex of WT and KO mice. In the lower portion of the sections it 
is well visible also the corpus callosum (cc). Double-labeled and merged confocal images of GFAP (red) plus NeuroTrace Nissl staining (green) 
(scale bars = 100 μm). E, Western blotting and its densitometry of GFAP. Immunoblot images are cropped from different parts of the same gel. F, 
Histogram of the number of GFAP positive cells in the cerebral cortex of WT and KO mice. G-K, Histograms of the Sholl analysis of microglia in 
the cerebral cortex of WT and KO mice showing the perimeter (G) and the cross-sectional area of the Iba1 + cells (H), the number of intersections 
(I), and the number of nodes/branch points at the different radii (J). All results are mean ± SEM or representative of six animals per group (WT and 
KO) *P < .05, **P < .01, and ***P < .001 vs WT by unpaired Student's t test
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of their processes (Figure 4G-J), suggesting the different 
state of microglia in KO mice compared to WT. To show 
that the reduced expression of genes associated with neural 
plasticity and the exacerbated inflammation observed in KO 
mice might have a physiological impact in this mouse model 
deficient for DHA synthesis, we also performed some behav-
ioral analyses. Thus, to examine responses to an unfamiliar 
environment, Elovl2 WT and KO mice were evaluated in the 
open field test. Our results show that even if no statistical 
difference was present  in the number of visits to the center 
zone, the percentage of time spent and the distance covered in 
the center zone were statistically significant between the two 
groups of animals (Figure 5A). The same set of animals was 
also subjected to the NOR test, in which KO animals show a 
tendency to spend less time, although not significant, at the 
novel object compared to WT (Figure 5B), suggesting no 
deficit in object memory. Next, we also evaluated the spatial 
learning and memory with the Barnes Maze test in a small 
group of female mice and, also in this case, no differences be-
tween WT and KO were observed in the learning curve and in 
the amount of time spent in the target quadrant (Figure 5C). 
These results suggest that even if the deficiency of endoge-
nous DHA affects inflammatory and neuroplasticity markers, 
it does not overall influence behavioral functions.
3.4 | Neuroplasticity and 
neuroinflammatory markers are restored by 
dietary DHA supplementation
Given the alteration observed in the cerebral cortex of 
KO mice in terms of expression of neuroplasticity and 
F I G U R E  5  DHA deficiency does not alter behavioral functions. A, Individual exploration trajectories showing the change in the exploratory 
activity of WT and KO mice. Brown lines indicate locomotion (horizontal movements), blue lines indicate rears (vertical movements), and green 
lines indicate center area and corners. Exploratory activity was calculated as the number of visits to the center zone, percentage of time spent in 
the center zone, and percentage of distance in the center zone. Data are shown as mean ± SEM of 12 WT and 16 KO mice and analyzed by the 
unpaired Student's t test. B, Working memory consolidation with two objects (novel and familiar) evaluated as the percentage of time spent at 
exploring the objects. Data are shown as mean ± SEM of seven animals per group (WT and KO) and analyzed by the unpaired Student's t test. C, 
Spatial and learning memory evaluated as the ability of animals to seek out for escape holes (time spent in quadrants of target, opposite, negative or 
positive holes). Data are shown as mean ± SEM of 8 WT and 7 KO and analyzed by the unpaired Student's t test
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neuroinflammation markers, we next questioned whether 
a short-term dietary supplementation with DHA could re-
store some of these markers in the cerebral cortex of KO 
mice. In particular, the reintroduction of DHA in KO mice 
significantly increased the mRNA expression levels of Arc-1 
and reduced that of IL-1β and Casp1 compared to KO, with 
IL-1β and Casp1 also showing comparable levels to those of 
WT mice (Figure 6A). This DHA-induced effect was also 
F I G U R E  6  Dietary supplementation with DHA restores neuroplasticity and microglia status in the cerebral cortex. A, mRNA expression of 
Arc-1, IL-1β, and Casp1 in the cortex by qRT-PCR. Data are shown as mean ± SEM of four animals per group (WT, KO, and KO + DHA), each 
in duplicate. ***P < .001 vs WT and *P < .05 vs KO by one-way ANOVA. B, Protein expression of Arc-1 by western blotting and (C) level of 
IL-1β by ELISA. Data are shown as mean ± SEM of four animals per group (WT, KO, and KO + DHA), each in duplicate. ***P < .001 vs WT 
and *P < .05 vs KO by one-way ANOVA followed by Bonferroni post-hoc test. D, Immunofluorescence staining of microglia in the cortex of WT, 
KO, and DHA-supplemented KO (KO + DHA) mice. Double-labeled and merged confocal images of Iba1 (red) plus NeuroTrace Nissl staining 
(green) in the cerebral cortex (scale bars = 100 μm). Inset: Single-labeled images of Iba1 staining (scale bars = 10 μm). E, Histogram of the number 
of Iba1 positive cells in the cerebral cortex. Data are shown as mean ± SEM of six animals per group (WT, KO, and KO + DHA). ***P < .001 and 
**P < .01 by one-way ANOVA followed by the Bonferroni post-hoc test (F-I). Histograms of the Sholl analysis of microglia in the cerebral cortex 
of WT, KO, and KO + DHA mice showing the perimeter (F) and the cross-sectional area of the cells (G), the number of intersections (H), and the 
number of nodes/branch points of intersections at the different radii (I). Results are mean ± SEM or representative of six animals per group (WT, 
KO, and KO + DHA). **P < .01 and ***P < .001 by one-way ANOVA followed by Bonferroni post-hoc test. J, Schematic representation of DHA 
deficiency-induced impact on brain plasticity and inflammation markers
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corroborated analyzing the protein levels of Arc-1 and IL-1β 
(Figure 6B-C), with the former showing even higher levels 
of expression compared to WT (Figure 6B), while the levels 
of the latter were equal to WT mice (Figure 6C). Similarly, 
we observed a marked and significant decrease in the num-
ber of Iba1  +  cells in DHA-supplemented KO mice com-
pared to KO mice (Figure 6D-E), showing that the number 
of Iba1 + cells was comparable to WT mice (Figure 6F-I). Of 
note, the DHA-deficiency-induced changes in the morphol-
ogy of microglia observed in KO mice were also counter-
acted upon DHA supplementation, with microglia presenting 
a morphological state similar to that observed in WT mice 
(Figure 6D,F-I). These findings were supported by the evi-
dence that DHA supplementation significantly restored the 
brain levels of DHA (Figure S1A), suggesting a key role of 
DHA in mediating our observed effects. Of note, DHA sup-
plementation did not impact on body weight (Figure S1B) or 
food intake (Figure S1C).
Furthermore, to rule out the possibility of stain infiltrated 
Iba1 + monocytes/macrophages from the periphery, we also 
performed double immunofluorescence combining Iba1 with 
TMEM-119, a more specific marker of resident microg-
lia.41 Confocal analysis of Iba1/TMEM-119 confirmed that 
the number of microglia TMEM-119  +  was significantly 
higher in KO mice and reduced upon DHA reintroduction, 
but also demonstrated that both markers perfectly colocalize 
(Figure S2), thus confirming that the DHA-induced modula-
tion of neuroinflammation more likely involves only resident 
microglia.
4 |  DISCUSSION
The beneficial properties of dietary ω-3 polyunsaturated fatty 
acids (PUFA), particularly of DHA, have been recognized 
for decades and their metabolic dysfunction has been linked 
to a range of diseases including inflammatory and neurode-
generative disorders.42,43 Indeed, DHA is an important com-
ponent of neural membranes, regulating membrane fluidity, 
permeability, and viscosity in synaptic membranes as well as 
playing a key role in modulating neurotransmission and syn-
aptic function and plasticity.44 However, although its crucial 
function in brain processes is undisputed, the specific role of 
the endogenous synthesis of DHA in the brain and how this 
affects neural plasticity and inflammation is still obscure.
Thus, in this study, we thoroughly investigated for 
the first time whether the endogenous synthesis of DHA 
can impact on markers of brain plasticity and inflamma-
tion. For this purpose, we used mice deficient for Elovl2 
(Elovl2−/−), a key enzyme involved in the synthesis of 
DHA.45 Our group has previously shown that these mice 
are characterized by severely reduced DHA levels in testis, 
serum, liver, mammary gland and white adipose tissue6,26,44 
as well as by a pro-inflammatory status of innate immune 
cells.25 In the present work, we collected the unprecedented 
evidence of acyl-CoA levels in brain by targeted lipidom-
ics and we demonstrated that Elovl2-mediated endogenous 
DHA synthesis plays a role in the expression of several 
brain plasticity and inflammatory markers. Although, to 
date, it is unclear why brain phospholipids are specifically 
enriched in DHA and low in DPA and EPA, the fact that 
DHA enrichment is conserved across species46,47 suggests 
that there is a highly specific requirement for this essential 
fatty acid in neuronal membranes. Indeed, we found a sig-
nificant downregulation of several neural plasticity factors 
(Arc-1, Egr-1, and BDNF) and a concomitant upregula-
tion of key inflammatory markers (TNF, IL-1β, iNOS, and 
Casp1) in Elovl2−/− mice. Interestingly, variations of such 
markers were particularly evident in the cerebral cortex 
and not in the total brain, confirming the essential role of 
this fatty acid in the brain region where it is mostly abun-
dant and corroborating our previous results demonstrating 
the unique role of Elovl2 in the formation of DHA in the 
brain.26 Our data are in line with previous findings demon-
strating that the expression of these markers as well as their 
related learning and memory functions is modulated by 
omega-3 fatty acids in the adult brain.36,48,49
However, although decreases in BDNF and Arc-1 ex-
pression are commonly linked to the development of long-
term cognitive and behavioral alterations11,13,50,51 and their 
reduction in the prefrontal cortex are associated with de-
pression,50 the mechanism underlying brain DHA reduc-
tions and behavioral alterations are still a matter of debate. 
In addition, considering the substantial evidence regard-
ing the importance of DHA during brain development and 
on resulting cognitive functions, further investigations 
are needed to assess a functional relationship between 
cognitive/behavioral alterations and DHA deficiency in 
Elovl2−/− mice.
Of note, it is now well established that the brain has fun-
damental interactions with the immune system.52 One of the 
most exciting aspects of such neuro-immune communica-
tion is that the immune system actively participates in brain 
functions and synaptic plasticity. In particular glial cells have 
emerged as active players of synapses, able to shape synapse 
structure and function.53 Indeed, we observed a significant 
upregulation of several genes involved in neuroinflammation 
such as iNOS, caspase-1, and pro-inflammatory cytokines 
(IL-1β and TNF) in the cerebral cortex of DHA-deficient 
mice; such high and sustained pro-inflammatory status is 
detrimental for both neurons and glial cells, resulting in cell 
dysfunction or death54,55 as well as in the pathogenesis of 
several cognitive disorders.56-58 Of note, several cytokines 
have been reported to suppress synaptic plasticity by sup-
pressing Arc expression in a BDNF-dependent manner and 
the latter, together with Egr-1, is a transcriptional regulator 
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of Arc, thus accounting for our marked changes in Arc-1 at 
both mRNA and protein level, while Erg-1 and BDNF only 
show changes in their mRNA but not protein. However, the 
notion that pro-inflammatory cytokines are only expressed in 
the brain in response to pathological stimuli has been chal-
lenged by emerging data, indicating that certain cytokines 
can also play an active role in synaptic plasticity in physio-
logical condition.59
Yet, the ability of fatty acids to modulate both inflam-
mation and synaptic functions is coming to the foreground 
and alterations of their availability, either due to insuffi-
cient dietary consumption or impaired metabolism, might 
play a role in the pathogenesis of several cognitive disor-
ders.38 In this regard, significant differences in the synap-
tic proteome of DHA-adequate and DHA-deficient mouse 
brains have been reported60 providing a molecular basis for 
the significant impact of nutritional DHA on some brain 
functions such as learning and memory. The evidence 
that free DHA can enter the brain through the mfsd2a and 
that this transporter is regulated both in Elovl2 mice and 
upon DHA supplementation suggests not only that Major 
Facilitator Superfamily Domain containing 2a (Mfsd2a) 
plays a compensatory role to balance the DHA levels in the 
brain of Elovl2 mice but also that exists a dynamic inter-
play between DHA synthesis and DHA uptake in the con-
trol of systemic levels.
Intriguingly, glial cells play a crucial role in the regula-
tion of both inflammatory and brain plasticity processes.61,62 
The fact that our findings revealed the alteration of microg-
lia, but not of astrocytes, in Elovl2−/− mice, suggests that this 
specific resident immune cell of the brain is specifically af-
fected by DHA deficiency. In particular, not only did we find 
that the number of Iba1 + cells in the cerebral cortex is in-
creased in DHA deficient mice, but also that its morphology 
undergoes significant changes. Microglia are dynamic cells 
whose morphological changes seem to be associated with 
their functional activities, whereby ramified microglia act as 
surveying cells, whereas hyper-ramified microglia are char-
acterized by increased secretion of pro-inflammatory medi-
ators.62 This suggests that microglia might be responsible 
for the up-regulation of iNOS, IL-1β, and TNF observed in 
Elovl2−/− mice. Although our findings do not clarify the pre-
cise cellular source of cytokines, however, our results suggest 
a temporal correlation between the microglia morphological 
changes and cytokines production. More studies are required 
to establish the cellular source of cytokines and, in particu-
lar, to demonstrate that their production can be attributed to 
microglia.
Furthermore, since microglia also play a role in syn-
aptic remodeling and neuronal plasticity,61 it is also pos-
sible that such activated inflammatory status is somehow 
associated with the downregulation of markers of synaptic 
plasticity in Elovl2−/− mice. This is particularly important 
since the brain and the immune systems are engaged in a 
bidirectional crosstalk and our data suggest that microg-
lia might engage in mediating such a complex interaction. 
Furthermore, the fact that such changes are even influenced 
by DHA deficiency alone, in absence of any brain insult, 
suggests that ω-3 essential fatty acid is a master regulator of 
brain responses and an intriguing interface between “mind” 
and “body.” However, only a few groups have evaluated 
the consequences of PUFAs manipulation on microglia in 
vivo and in cerebral cortex of adult mice after a pathologi-
cal event.63,64 Accordingly, the evidence that reintroducing 
DHA in the diet of Elovl2−/− mice restored the expression 
levels of key neuroinflammatory (IL-1β and Casp-1) and 
neuroplasticity (Arc-1) markers as well as prevented the 
microglia  DHA deficiency-induced morphologic changes 
in the cerebral cortex further corroborates our findings. Of 
note, whether such DHA-induced neuroprotective effects 
are mediated by this fatty acid alone or by its derived and 
specialized pro-resolving mediators (SPMs) have yet to 
be unraveled. The discoveries that several DHA-derived 
SPMs, such as resolvins or neuroprotectins, play critical 
roles in modulating microglia responses as well ad in the 
modulation of reactive species24,65-67 is suggestive of their 
possible involvement in controlling neuroplasticity and in 
representing a link between the immune and the central ner-
vous systems. In addition, our findings show that even in 
the absence of inflammatory stimuli or without the induc-
tion of specific diseases, systemic DHA deficiency induces 
a basal inflammatory activity, which is characterized by an 
overall upregulation of several inflammatory markers; how-
ever, this only has a little impact on behavioral functions. 
Further experiments to prove whether such DHA-deficient 
mice are more responsive to inflammatory events or are 
more susceptible to chronic neuroinflammatory diseases 
or cognitive disorders are needed. Yet the evidence that a 
ω-3 deficient diet is associated with exacerbated inflamma-
tion and memory deficits in another mice model exposed 
prenatally to LPS68 suggests that DHA-induced profound 
and macroscopic cognitive alterations appear mostly under 
inflammatory conditions and account for the discrete be-
havioral dysfunctions observed here. It is important to add 
that since the Iba1 microglia marker can also stain macro-
phages migrated from the periphery, TMEM-119/Iba1 co-
localization excludes the possibility that endogenous DHA 
synthesis may also impact recruitment and activation of 
infiltrated cortical monocytes/macrophages.
Furthermore, we cannot exclude also the possibility that 
our DHA-induced effects on microglia are mediated by 
a direct action on these cells or are indirectly mediated by 
influencing other molecules released by astrocytes or even 
neurons, calling for future mechanistic studies unraveling the 
cellular and molecular signaling pathways. The unraveling of 
these issues would also be crucial to understand whether the 
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changes in markers of brain plasticity and neuroinflammation 
take place within the same cells and are linked to one another 
and what are the mechanisms underlying their interaction.
In conclusion, as summarized in Figure 6J, this study has 
highlighted the important role of the DHA-generating Elovl2 
enzyme in modulating brain neuroplasticity and inflamma-
tion, with conceivable and potential implications in affecting 
CNS homeostasis. Indeed, our findings suggest that the enzy-
matic machinery that leads to DHA synthesis is involved, at 
least in part, in the maintenance of brain functions and sup-
ports the notion that diets rich in DHA could be sufficient 
to activate some compensatory pathways that might reduce 
neuroinflammation.
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